ATE293982T1 - Pharmazeutische kombination von adenosine a-2a und beta-2-adrenergen rezeptoren agonisten - Google Patents

Pharmazeutische kombination von adenosine a-2a und beta-2-adrenergen rezeptoren agonisten

Info

Publication number: ATE293982T1
Authority: AT; Austria
Prior art keywords: adenosine; beta; pharmaceutical combination; adrenergic receptors; receptors agonists
Prior art date: 2001-12-06

Application number

AT02785778T

Other languages

English (en)

Inventor

Michael Yeadon

Original Assignee

Pfizer

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-12-06

Filing date

2002-11-28

Publication date

2005-05-15

2002-11-28 Application filed by Pfizer filed Critical Pfizer

2005-05-15 Application granted granted Critical

2005-05-15 Publication of ATE293982T1 publication Critical patent/ATE293982T1/de

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Pulmonology (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Molecular Biology (AREA)
Bioinformatics & Cheminformatics (AREA)
Biotechnology (AREA)
Biochemistry (AREA)
Genetics & Genomics (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Saccharide Compounds (AREA)
Medicinal Preparation (AREA)

AT02785778T 2001-12-06 2002-11-28 Pharmazeutische kombination von adenosine a-2a und beta-2-adrenergen rezeptoren agonisten ATE293982T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB0129270.5A GB0129270D0 (en)	2001-12-06	2001-12-06	Pharmaceutical combination
PCT/IB2002/005057 WO2003047598A1 (en)	2001-12-06	2002-11-28	Pharmaceutical combinations of adenosine a-2a and beta-2-adrenergic receptor agonists

Publications (1)

Publication Number	Publication Date
ATE293982T1 true ATE293982T1 (de)	2005-05-15

Family

ID=9927164

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT02785778T ATE293982T1 (de)	2001-12-06	2002-11-28	Pharmazeutische kombination von adenosine a-2a und beta-2-adrenergen rezeptoren agonisten

Country Status (38)

Country	Link
EP (1)	EP1455799B1 (de)
JP (1)	JP2005513041A (de)
KR (1)	KR100685557B1 (de)
CN (1)	CN1856314A (de)
AP (2)	AP2004003082A0 (de)
AR (1)	AR037634A1 (de)
AT (1)	ATE293982T1 (de)
AU (1)	AU2002351066B2 (de)
BR (1)	BR0214998A (de)
CA (1)	CA2469085A1 (de)
CO (1)	CO5580752A2 (de)
DE (1)	DE60203934T2 (de)
DK (1)	DK1455799T3 (de)
EA (1)	EA200400639A1 (de)
EC (1)	ECSP045132A (de)
ES (1)	ES2239728T3 (de)
GB (1)	GB0129270D0 (de)
GT (1)	GT200200258A (de)
HN (1)	HN2002000348A (de)
HR (1)	HRP20040517A2 (de)
HU (1)	HUP0402540A3 (de)
IS (1)	IS7280A (de)
MA (1)	MA27150A1 (de)
MX (1)	MXPA04005506A (de)
NO (1)	NO20042839L (de)
NZ (1)	NZ533054A (de)
OA (1)	OA12738A (de)
PA (1)	PA8560701A1 (de)
PE (1)	PE20030834A1 (de)
PL (1)	PL370739A1 (de)
PT (1)	PT1455799E (de)
PY (1)	PY0228254A (de)
SV (1)	SV2004001426A (de)
TN (1)	TNSN04101A1 (de)
TW (1)	TWI256388B (de)
UY (1)	UY27566A1 (de)
WO (1)	WO2003047598A1 (de)
ZA (1)	ZA200403966B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR100785969B1 (ko) *	2004-05-12	2007-12-14	동아제약주식회사	Ｆｇｆ2를 유효성분으로 포함하는 천식 및 만성폐쇄성폐질환 예방 또는 치료제
US9757395B2 (en)	2012-12-20	2017-09-12	Otitopic Inc.	Dry powder inhaler and methods of use
US9757529B2 (en)	2012-12-20	2017-09-12	Otitopic Inc.	Dry powder inhaler and methods of use
CA2910766C (en)	2013-04-30	2020-12-15	Otitopic Inc.	Dry powder formulations and methods of use
CA3076353A1 (en)	2017-09-22	2019-03-28	Otitopic Inc.	Dry powder compositions with magnesium stearate
US10786456B2 (en)	2017-09-22	2020-09-29	Otitopic Inc.	Inhaled aspirin and magnesium to treat inflammation
WO2022050230A1 (ja) *	2020-09-03	2022-03-10	学校法人埼玉医科大学	アデノシン受容体の活性化を抑制する組成物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0003960D0 (en) *	2000-02-18	2000-04-12	Pfizer Ltd	Purine derivatives
TWI227240B (en) *	2000-06-06	2005-02-01	Pfizer	2-aminocarbonyl-9H-purine derivatives

2001
- 2001-12-06 GB GBGB0129270.5A patent/GB0129270D0/en not_active Ceased
2002
- 2002-11-14 PY PY200200228254A patent/PY0228254A/es unknown
- 2002-11-28 ES ES02785778T patent/ES2239728T3/es not_active Expired - Lifetime
- 2002-11-28 CA CA002469085A patent/CA2469085A1/en not_active Abandoned
- 2002-11-28 DE DE60203934T patent/DE60203934T2/de not_active Expired - Fee Related
- 2002-11-28 DK DK02785778T patent/DK1455799T3/da active
- 2002-11-28 OA OA1200400164A patent/OA12738A/en unknown
- 2002-11-28 HR HR20040517A patent/HRP20040517A2/hr not_active Application Discontinuation
- 2002-11-28 AU AU2002351066A patent/AU2002351066B2/en not_active Ceased
- 2002-11-28 AT AT02785778T patent/ATE293982T1/de not_active IP Right Cessation
- 2002-11-28 JP JP2003548853A patent/JP2005513041A/ja active Pending
- 2002-11-28 CN CNA028244168A patent/CN1856314A/zh active Pending
- 2002-11-28 EP EP02785778A patent/EP1455799B1/de not_active Expired - Lifetime
- 2002-11-28 HU HU0402540A patent/HUP0402540A3/hu unknown
- 2002-11-28 BR BR0214998-2A patent/BR0214998A/pt not_active IP Right Cessation
- 2002-11-28 MX MXPA04005506A patent/MXPA04005506A/es active IP Right Grant
- 2002-11-28 PT PT02785778T patent/PT1455799E/pt unknown
- 2002-11-28 WO PCT/IB2002/005057 patent/WO2003047598A1/en not_active Ceased
- 2002-11-28 EA EA200400639A patent/EA200400639A1/ru unknown
- 2002-11-28 NZ NZ533054A patent/NZ533054A/en unknown
- 2002-11-28 KR KR1020047008609A patent/KR100685557B1/ko not_active Expired - Fee Related
- 2002-11-28 AP APAP/P/2004/003082A patent/AP2004003082A0/en unknown
- 2002-11-28 PL PL02370739A patent/PL370739A1/xx not_active Application Discontinuation
- 2002-11-28 AP APAP/P/2004/003053A patent/AP2004003053A0/en unknown
- 2002-11-29 TW TW091134818A patent/TWI256388B/zh not_active IP Right Cessation
- 2002-12-03 HN HN2002000348A patent/HN2002000348A/es unknown
- 2002-12-03 PE PE2002001164A patent/PE20030834A1/es not_active Application Discontinuation
- 2002-12-04 AR ARP020104685A patent/AR037634A1/es unknown
- 2002-12-05 GT GT200200258A patent/GT200200258A/es unknown
- 2002-12-05 SV SV2002001426A patent/SV2004001426A/es not_active Application Discontinuation
- 2002-12-05 UY UY27566A patent/UY27566A1/es not_active Application Discontinuation
- 2002-12-06 PA PA20028560701A patent/PA8560701A1/es unknown
2004
- 2004-05-21 ZA ZA200403966A patent/ZA200403966B/xx unknown
- 2004-05-21 IS IS7280A patent/IS7280A/is unknown
- 2004-06-02 MA MA27710A patent/MA27150A1/fr unknown
- 2004-06-03 CO CO04052108A patent/CO5580752A2/es not_active Application Discontinuation
- 2004-06-04 TN TNP2004000101A patent/TNSN04101A1/fr unknown
- 2004-06-04 EC EC2004005132A patent/ECSP045132A/es unknown
- 2004-07-05 NO NO20042839A patent/NO20042839L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
TW200300759A (en)	2003-06-16
JP2005513041A (ja)	2005-05-12
CN1856314A (zh)	2006-11-01
KR100685557B1 (ko)	2007-02-22
PL370739A1 (pl)	2005-05-30
PY0228254A (es)	2004-06-01
ZA200403966B (en)	2005-06-22
HUP0402540A2 (hu)	2005-07-28
AU2002351066A1 (en)	2003-06-17
IS7280A (is)	2004-05-21
PA8560701A1 (es)	2004-05-07
GB0129270D0 (en)	2002-01-23
EA200400639A1 (ru)	2004-12-30
PT1455799E (pt)	2005-08-31
WO2003047598A1 (en)	2003-06-12
HUP0402540A3 (en)	2008-04-28
ECSP045132A (es)	2004-07-23
DE60203934T2 (de)	2006-02-23
KR20050044697A (ko)	2005-05-12
AU2002351066B2 (en)	2007-10-18
CA2469085A1 (en)	2003-06-12
DK1455799T3 (da)	2005-06-27
AP2004003082A0 (en)	2004-09-30
AP2004003053A0 (en)	2004-06-30
HRP20040517A2 (en)	2004-10-31
HN2002000348A (es)	2005-02-04
PE20030834A1 (es)	2003-10-08
EP1455799A1 (de)	2004-09-15
DE60203934D1 (de)	2005-06-02
BR0214998A (pt)	2004-12-28
TWI256388B (en)	2006-06-11
TNSN04101A1 (fr)	2006-06-01
UY27566A1 (es)	2003-07-31
EP1455799B1 (de)	2005-04-27
OA12738A (en)	2006-06-29
MA27150A1 (fr)	2005-01-03
GT200200258A (es)	2003-08-22
MXPA04005506A (es)	2004-12-10
NZ533054A (en)	2007-02-23
CO5580752A2 (es)	2005-11-30
AR037634A1 (es)	2004-11-17
ES2239728T3 (es)	2005-10-01
NO20042839L (no)	2004-07-05
SV2004001426A (es)	2004-05-07

Legal Events

Date

Code

Title

Description

2005-12-15

UEP

Publication of translation of european patent specification

Ref document number: 1455799

Country of ref document: EP

2010-08-15

REN

Ceased due to non-payment of the annual fee

Publication	Publication Date	Title
DE60201988D1 (de)	2004-12-23	Pharmazeutische dosierungsform von amorphem nilfenavir mesylat
ATE396171T1 (de)	2008-06-15	Acylierte 6,7,8,9-tetrahydro-5h- benzocycloheptenyl-amine und deren pharmazeutische verwendung
ATE430124T1 (de)	2009-05-15	Arylanilin beta-2 adrenergische rezeptor agoniste
DE60208159D1 (de)	2006-01-26	Antagonisten von mcp-1 tätigkeit und deren verwendungsmethoden
CY2007013I2 (el)	2011-02-02	Νεες συνταγοποιησεις αγωνιστου εξεντινης και μεθοδοι χορηγησης αυτων
BR9916857A (pt)	2001-12-04	4 heteroaril diarilaminas
DE60234376D1 (de)	2009-12-24	3-beta-d-ribofuranosylthiazolo(4,5-delta)pyridimin-nucleoside und ihre verwendung
CY2014003I1 (el)	2015-12-09	Φαρμακοτεχνικες μορφες εχινοκανδινης που περιεχουν επιφανειοδραστικα που σχηματιζουν μικκυλιο
NO20043064L (no)	2004-09-17	1-alkyl-1-azoniabisyklo [2.2.2] oktankarbamatderivater og anvendelse av disse som muskarine reseptorantagonister
ID29578A (id)	2001-09-06	Turunan-turunan indeno-, nafto- dan benzosikloheptadihidrotiazol serta pembuatan dan penggunaannya sebagai obat-obatan anorektik
DE60222647D1 (de)	2007-11-08	Urea derivate als integrin alpha 4 antagonisten
EP1423431A4 (de)	2005-04-27	Antikörper gegen vla-1
DE60201868D1 (de)	2004-12-16	Spritzenkörper und Zylinderhalter
AR025883A1 (es)	2002-12-18	Utilizacion de antagonistas de los receptores de los cannabinoides centrales para la preparacion de medicamentos
IL163613A (en)	2010-12-30	Partial or full agonists of a1 adenosine receptors and pharmaceutical compositions comprising the same
DE60037816D1 (de)	2008-03-06	Pharmazeutische formulierung enthaltend megalatran und dessen pro-pharmaka
PT1208100E (pt)	2003-07-31	Antagonistas selectivos de receptores de adenosina a2b
ATE293982T1 (de)	2005-05-15	Pharmazeutische kombination von adenosine a-2a und beta-2-adrenergen rezeptoren agonisten
NO20023144D0 (no)	2002-06-28	Kompleks omfattende OCIF og polysakkarid
DE60017465D1 (de)	2005-02-17	Kombination aus fluazuron und ivermectin gegen parasiten
PT1448566E (pt)	2006-08-31	Antagonistas do receptor quimioquina e metodos de utilizacao do mesmo
EE200300454A (et)	2003-12-15	Bitsüklilised guanidiini derivaadid ja nende terapeutiline kasutamine
EP1324763A4 (de)	2007-10-31	Stat3-agonisten und antagonisten und ihre therapeutischen anwendungszwecke
ATE338548T1 (de)	2006-09-15	Pyridoindolonderivate und antikrebsmittel enthaltende pharmazeutische mischungen
IS7277A (is)	2004-05-21	Samsetning kjörvíss PDE4 hindra og adrenergísks beta-2 viðtaka gerandefnis